To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ATF4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
320 representative clones for gene ATF4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CN484649 eye .a 1 to 596 19 to 613   tiling clone,   595/613
(97 %)
8 diff
(98.7 %id)
BG983931 colon_normal .a 31 to 557 1 to 528       528/528
(100 %)
9 diff
(98.3 %id)
BX465106 B cells (Ramos cell line) .a 405 to 1258 854 to 1       854/854
(100 %)
2 diff
(99.8 %id)
CA946975 Pancreas, Purified pancreatic islet .a 424 to 894 1 to 471   fully sequenced,   471/471
(100 %)
0 diff
(100 %id)
AA405874 ovarian tumor, ovary .a 442 to 962 1 to 520   tiling clone, fully sequenced,   520/520
(100 %)
1 diff
(99.9 %id)
TI_154126073   .a 448 to 1313 929 to 84   AAA   846/934
(90 %)
25 diff
(97.4 %id)
CR736944 uterus .a 465 to 1175 1 to 712       712/717
(99 %)
3 diff
(99.6 %id)
BI858594 breast, mammary adenocarcinoma, cell line .a 484 to 1311 1 to 831   AAA   831/831
(100 %)
11 diff
(98.7 %id)
TI_57191517   .a 484 to 1311 77 to 907   AAA   831/831
(100 %)
11 diff
(98.7 %id)
AI339383 pooled germ cell tumors .a 538 to 1313 776 to 1       776/776
(100 %)
18 diff
(97.7 %id)
AI479769 anaplastic oligodendroglioma, brain .a 542 to 1313 765 to 1       765/769
(99 %)
18 diff
(97.7 %id)
AL048300 uterus .a 546 to 1313 796 to 28   AAA   769/771
(99 %)
14 diff
(98.2 %id)
TI_154103723   .a 546 to 1313 844 to 78   AAA   767/818
(93 %)
26 diff
(96.9 %id)
TI_154046541   .a 547 to 1312 855 to 95   AAA   761/970
(78 %)
6 diff
(99.4 %id)
TI_154039420   .a 551 to 1313 840 to 84   AAA   757/941
(80 %)
8 diff
(99.2 %id)
TI_154100729   .a 563 to 1313 827 to 87   AAA   741/779
(95 %)
15 diff
(98.1 %id)
BQ898060 epidermoid carcinoma, cell line, salivary gland .a 565 to 1319 1 to 757       757/849
(89 %)
6 diff
(99.3 %id)
AI436395 B-cell, chronic lymphotic leukemia .a 574 to 1314 743 to 1       743/743
(100 %)
8 diff
(99.0 %id)
BM999536 Fibrosarcoma .a 574 to 1313 755 to 19   AAA   737/737
(100 %)
3 diff
(99.6 %id)
CA442297 Fibrosarcoma .a 579 to 1313 750 to 19   AAA   732/735
(99 %)
3 diff
(99.6 %id)
BI062411 uterus_tumor .a 590 to 1244 1 to 655       655/655
(100 %)
0 diff
(100 %id)
BI063063 uterus_tumor .a 590 to 1223 1 to 634       634/634
(100 %)
0 diff
(100 %id)
TI_149288905   .a 604 to 1313 794 to 85   AAA   710/711
(99 %)
5 diff
(99.3 %id)
TI_149281788   .a 611 to 1318 798 to 91   AAA   708/711
(99 %)
4 diff
(99.5 %id)
TI_154049619   .a 621 to 1318 803 to 110   AAA   694/896
(77 %)
6 diff
(99.4 %id)
TI_154061622   .a 621 to 1313 781 to 92   AAA   690/902
(76 %)
8 diff
(99.2 %id)
TI_154018842   .a 625 to 1313 787 to 101   AAA   687/711
(96 %)
3 diff
(99.6 %id)
CD368567 Alveolar Macrophage, lung .a 634 to 1313 698 to 19   AAA   680/680
(100 %)
0 diff
(100 %id)
AW001098 colon, colonic mucosa from 3 patients with Crohn'sdisease .a 644 to 1313 670 to 1       670/670
(100 %)
11 diff
(98.4 %id)
BM716193 eye, RPE and Choroid .a 659 to 1313 1 to 654   AAA   654/654
(100 %)
1 diff
(99.9 %id)
BU630581 cell lines, Chondrosarcoma .a 664 to 1313 668 to 19   AAA   650/650
(100 %)
0 diff
(100 %id)
CD367965 Alveolar Macrophage, lung .a 664 to 1318 673 to 19   tiling clone, AAA   655/655
(100 %)
0 diff
(100 %id)
BQ181971 Knee, Osteoarthritic Cartilage .a 666 to 1318 666 to 14   AAA   653/653
(100 %)
0 diff
(100 %id)
CA412429 Chondrosarcoma Grade II, Left Pelvis .a 666 to 1312 665 to 19   AAA   647/647
(100 %)
0 diff
(100 %id)
CA416321 Chondrosarcoma Cell line .a 668 to 1313 664 to 19   AAA   646/646
(100 %)
0 diff
(100 %id)
BU679648 lung .a 669 to 1318 668 to 19   AAA   650/650
(100 %)
0 diff
(100 %id)
BE717015 head_neck .a 675 to 1157 494 to 13       482/495
(97 %)
0 diff
(100 %id)
BI057613 placenta_normal .a 675 to 1011 378 to 42       337/378
(89 %)
0 diff
(100 %id)
ES316032 melanoma cell line .a 678 to 1065 423 to 36     Submitted on the opposite strand 388/482
(80 %)
0 diff
(100 %id)
CA445135 lung, Metastatic Chondrosarcoma .a 680 to 1313 652 to 19   AAA   634/634
(100 %)
0 diff
(100 %id)
CA420336 Bone, Enchondroma cell line .a 680 to 1313 652 to 19   AAA   634/634
(100 %)
0 diff
(100 %id)
BU630351 cell lines, Chondrosarcoma .a 680 to 1313 652 to 19   AAA   634/634
(100 %)
0 diff
(100 %id)
CA305917 Alveolar Macrophage, lung .a 680 to 1313 652 to 19   AAA   634/634
(100 %)
0 diff
(100 %id)
CA442996 Fibrosarcoma .a 682 to 1318 655 to 19   AAA   637/637
(100 %)
0 diff
(100 %id)
BF804350 colon_ins .a 686 to 1007 394 to 72     Submitted on the opposite strand 323/394
(81 %)
0 diff
(100 %id)
EC567905 Prostate .a 690 to 783 11 to 104       94/104
(90 %)
6 diff
(94.3 %id)
BF900976 marrow .a 695 to 1119 495 to 72     Submitted on the opposite strand 424/495
(85 %)
0 diff
(100 %id)
BQ331179 lung_tumor .a 699 to 1206 534 to 27       508/536
(94 %)
0 diff
(100 %id)
EC497255 Prostate .a 716 to 809 1 to 91       91/91
(100 %)
4 diff
(95.7 %id)
CR623979 B cells (Ramos cell line) Cot 25-normalized .a 728 to 1290 1 to 563       563/563
(100 %)
0 diff
(100 %id)
BI029843 marrow .a 739 to 1025 293 to 3       291/296
(98 %)
0 diff
(100 %id)
BF835946 head_neck .a 742 to 1155 416 to 3     Submitted on the opposite strand 414/416
(99 %)
0 diff
(100 %id)
BF802242 colon_ins .a 747 to 1134 433 to 46     Submitted on the opposite strand 388/433
(89 %)
0 diff
(100 %id)
AA187824   .a 753 to 1157 1 to 407     Submitted on the opposite strand 407/407
(100 %)
5 diff
(98.8 %id)
AW802794 uterus .a 757 to 1009 254 to 1       254/256
(99 %)
6 diff
(97.7 %id)
BF369436 placenta_normal .a 759 to 1084 366 to 34       333/366
(90 %)
0 diff
(100 %id)
EC513691.
matches multiple genes
Prostate .a 784 to 867 12 to 93     also hits gene ATF4C 82/93
(88 %)
6 diff
(93.6 %id)
BF827023 head_normal .a 791 to 919 148 to 20     Submitted on the opposite strand 129/148
(87 %)
0 diff
(100 %id)
BF855258 prostate_normal .a 791 to 1180 457 to 62     Submitted on the opposite strand 396/457
(86 %)
0 diff
(100 %id)
BF998221 placenta_normal .a 817 to 1068 275 to 19       257/275
(93 %)
0 diff
(100 %id)
BF919655 nervous_tumor .a 831 to 1142 313 to 1     Submitted on the opposite strand 313/313
(100 %)
23 diff
(92.7 %id)
CR601622 HeLa cells Cot 25-normalized .a 841 to 1284 1 to 444       444/444
(100 %)
0 diff
(100 %id)
BF086105 placenta_normal .a 852 to 1077 249 to 19       231/249
(92 %)
17 diff
(93.2 %id)
BF091750 testis_normal .a 852 to 1077 229 to 3       227/229
(99 %)
11 diff
(95.2 %id)
BF873817 lung_tumor .a 855 to 1150 300 to 5     Submitted on the opposite strand 296/300
(98 %)
0 diff
(100 %id)
BQ335376 marrow .a 862 to 1066 218 to 7       212/218
(97 %)
0 diff
(100 %id)
CA946703 Pancreas, Purified pancreatic islet .a 864 to 1313 449 to 1   fully sequenced,   449/449
(100 %)
0 diff
(100 %id)
BF814364 colon_ins .a 879 to 1062 211 to 29     Submitted on the opposite strand 183/211
(86 %)
0 diff
(100 %id)
CV398570 colon_ins .a 891 to 1068 185 to 2     Submitted on the opposite strand 361/383
(94 %)
12 diff
(96.9 %id)
AA405749 ovarian tumor, ovary .a 932 to 1311 380 to 1   fully sequenced,   380/380
(100 %)
0 diff
(100 %id)
CR605521 HeLa cells Cot 25-normalized .a 934 to 1316 1 to 383       383/383
(100 %)
0 diff
(100 %id)
AU132787   .b 1 to 796 2 to 796   tiling clone, capped   795/797
(99 %)
8 diff
(99.0 %id)
DT218526 brain .b 3 to 661 1 to 659       659/659
(100 %)
0 diff
(100 %id)
AU107695   .b 3 to 52 1 to 50       50/50
(100 %)
0 diff
(100 %id)
AU107697   .b 3 to 52 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BM788327 stomach .b 3 to 640 1 to 638       638/638
(100 %)
0 diff
(100 %id)
DT215841 brain .b 4 to 655 1 to 652       652/652
(100 %)
0 diff
(100 %id)
AU107696   .b 4 to 53 1 to 50       50/50
(100 %)
0 diff
(100 %id)
DA729428   .b 4 to 689 2 to 687   capped   686/690
(99 %)
4 diff
(99.5 %id)
AK057751 cerebellum .b 5 to 1418 5 to 1418 exact available from FLJ,   1414/1414
(100 %)
1 diff
(100.0 %id)
NM_182810.1   .b 5 to 1424 1 to 1420 exact RefSeq,   1420/1420
(100 %)
0 diff
(100 %id)
BM767404 Ascites, stomach .b 5 to 649 1 to 645       645/645
(100 %)
0 diff
(100 %id)
BM770608 Ascites, stomach .b 5 to 664 1 to 660       660/660
(100 %)
0 diff
(100 %id)
DT216789 brain .b 6 to 654 1 to 649       649/649
(100 %)
0 diff
(100 %id)
AU107703   .b 9 to 58 1 to 50       50/50
(100 %)
0 diff
(100 %id)
CR611425 T cells (Jurkat cell line) .b 11 to 1421 1 to 1411 exact     1411/1411
(100 %)
0 diff
(100 %id)
BM741209 Ascites, stomach .b 11 to 651 1 to 641       641/641
(100 %)
0 diff
(100 %id)
CR596727 T cells (Jurkat cell line) .b 13 to 1377 1 to 1365 exact     1365/1365
(100 %)
0 diff
(100 %id)
CR604584 fetal brain .b 18 to 821 1 to 804       804/804
(100 %)
0 diff
(100 %id)
CR604900 Placenta Cot 25-normalized .b 19 to 1421 1 to 1403 exact     1403/1403
(100 %)
0 diff
(100 %id)
CV810754 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 19 to 844 1 to 829       829/887
(93 %)
16 diff
(98.2 %id)
BC022088 Ovary, adenocarcinoma .b 22 to 1418 1 to 1397 exact tiling clone, available from MGC, AAA   1397/1397
(100 %)
0 diff
(100 %id)
CR591677 Placenta Cot 25-normalized .b 22 to 1386 1 to 1365 exact     1365/1365
(100 %)
0 diff
(100 %id)
CR592048 Neuroblastoma Cot 25-normalized .b 22 to 1404 1 to 1383 exact     1383/1383
(100 %)
0 diff
(100 %id)
CR603180 Placenta Cot 25-normalized .b 22 to 1408 1 to 1387 exact     1387/1387
(100 %)
0 diff
(100 %id)
CR605724 T cells (Jurkat cell line) .b 22 to 1386 1 to 1365 exact     1365/1365
(100 %)
0 diff
(100 %id)
CR606595 Neuroblastoma Cot 25-normalized .b 22 to 1363 1 to 1342 exact     1342/1342
(100 %)
0 diff
(100 %id)
CR606709 fetal brain .b 22 to 1405 1 to 1384 exact     1384/1384
(100 %)
0 diff
(100 %id)
CR607769 T cells (Jurkat cell line) Cot10-normalized .b 22 to 1392 1 to 1371 exact     1371/1371
(100 %)
0 diff
(100 %id)
CR617911 T cells (Jurkat cell line) .b 22 to 1366 1 to 1345 exact     1345/1345
(100 %)
0 diff
(100 %id)
CR619870 Placenta Cot 25-normalized .b 22 to 1389 1 to 1368 exact     1368/1368
(100 %)
0 diff
(100 %id)
CR621381 neuroblastoma .b 22 to 1380 1 to 1359 exact     1359/1359
(100 %)
0 diff
(100 %id)
CR625158 Placenta Cot 25-normalized .b 22 to 1386 1 to 1365 exact     1365/1365
(100 %)
0 diff
(100 %id)
BX375534 Neuroblastoma Cot 25-normalized .b 22 to 749 1 to 723   fully sequenced,   723/723
(100 %)
0 diff
(100 %id)
BX424753 brain, fetal brain .b 22 to 1079 1 to 1044       1044/1058
(98 %)
22 diff
(98.0 %id)
BX424754 brain, fetal brain .b 22 to 843 1 to 811       811/850
(95 %)
25 diff
(97.1 %id)
BX440433 brain, fetal brain .b 22 to 1062 1 to 1030       1030/1037
(99 %)
14 diff
(98.7 %id)
BX356334 Placenta Cot 25-normalized .b 22 to 728 1 to 699   fully sequenced,   699/699
(100 %)
0 diff
(100 %id)
BX398609 Placenta Cot 25-normalized .b 22 to 747 1 to 712   fully sequenced,   712/712
(100 %)
0 diff
(100 %id)
BX366850 Placenta Cot 25-normalized .b 22 to 896 1 to 875       875/875
(100 %)
4 diff
(99.6 %id)
BM463438 embryonal carcinoma, cell line, testis .b 22 to 925 1 to 905       905/978
(92 %)
15 diff
(98.5 %id)
CX761897 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 23 to 788 1 to 753     Submitted on the opposite strand 753/791
(95 %)
16 diff
(98.0 %id)
CR595416 B cells (Ramos cell line) .b 24 to 1386 1 to 1363 exact     1363/1363
(100 %)
0 diff
(100 %id)
CR605980 adult brain .b 24 to 1421 1 to 1398 exact     1398/1398
(100 %)
0 diff
(100 %id)
CR616253 placenta .b 24 to 1377 1 to 1354 exact     1354/1354
(100 %)
0 diff
(100 %id)
BX417431 placenta .b 24 to 1085 1 to 1052       1052/1105
(95 %)
19 diff
(98.3 %id)
BX421193 B cells (Ramos cell line) .b 24 to 984 1 to 957       957/1057
(90 %)
14 diff
(98.7 %id)
BX465107 B cells (Ramos cell line) .b 24 to 919 1 to 894       894/894
(100 %)
2 diff
(99.8 %id)
BX444468 adult brain, brain .b 24 to 1052 1 to 1021       1021/1021
(100 %)
11 diff
(99.0 %id)
BG030349 breast, mammary adenocarcinoma, cell line .b 24 to 702 1 to 683       683/984
(69 %)
7 diff
(99.3 %id)
BM452714 lymph, lymphoma, cell line .b 24 to 808 1 to 797       797/1105
(72 %)
15 diff
(98.7 %id)
BQ066841 lymph, lymphoma, cell line .b 24 to 875 1 to 864       864/1054
(81 %)
32 diff
(97.0 %id)
BU185187 ductal carcinoma, cell line, Pancreas .b 24 to 823 1 to 812       812/1069
(75 %)
19 diff
(98.3 %id)
BQ217576 embryonal carcinoma, cell line, testis .b 24 to 824 1 to 813       813/904
(89 %)
17 diff
(98.2 %id)
BQ878781 ductal carcinoma, cell line, Pancreas .b 24 to 848 1 to 837       837/923
(90 %)
34 diff
(96.4 %id)
BU839524 hepatocellular carcinoma, cell line, Liver .b 24 to 752 1 to 736       736/871
(84 %)
12 diff
(98.7 %id)
BQ931626 eye, normal pigmented retinal epithelium .b 24 to 789 1 to 774       774/1002
(77 %)
10 diff
(99.1 %id)
CF242860 Brain glioblastoma .b 24 to 789 1 to 772       772/938
(82 %)
10 diff
(99.0 %id)
CF127812 Chondrosarcoma Lung Metastasis cell lines, lung .b 24 to 765 1 to 742       742/742
(100 %)
1 diff
(99.9 %id)
TI_154193591   .b 24 to 1015 51 to 1024       974/1025
(95 %)
26 diff
(97.5 %id)
CV804036 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 25 to 752 1 to 727       727/727
(100 %)
3 diff
(99.6 %id)
CR590198 neuroblastoma .b 26 to 1404 1 to 1379 exact     1379/1379
(100 %)
0 diff
(100 %id)
CR606384 neuroblastoma .b 26 to 1397 1 to 1372 exact     1372/1372
(100 %)
0 diff
(100 %id)
CR614389 Neuroblastoma Cot 25-normalized .b 26 to 1389 1 to 1364 exact     1364/1364
(100 %)
0 diff
(100 %id)
CR614692 B cells (Ramos cell line) .b 26 to 1424 1 to 1399 exact     1399/1399
(100 %)
0 diff
(100 %id)
CR623334 Placenta Cot 25-normalized .b 26 to 1385 1 to 1360 exact     1360/1360
(100 %)
0 diff
(100 %id)
CR625892 neuroblastoma .b 26 to 1389 1 to 1364 exact     1364/1364
(100 %)
0 diff
(100 %id)
BX446109 neuroblastoma .b 26 to 974 1 to 945       945/945
(100 %)
4 diff
(99.6 %id)
BX428643 B cells (Ramos cell line) .b 26 to 711 686 to 1       686/686
(100 %)
2 diff
(99.8 %id)
CR605268 placenta .b 28 to 1409 1 to 1382 exact     1382/1382
(100 %)
0 diff
(100 %id)
BC016855 Colon, adenocarcinoma .b 29 to 1418 1 to 1390 exact available from MGC, AAA   1390/1390
(100 %)
0 diff
(100 %id)
CR601074 thymus .b 29 to 1382 1 to 1354 exact     1354/1354
(100 %)
0 diff
(100 %id)
BX415489 thymus .b 29 to 698 1 to 670   fully sequenced,   670/670
(100 %)
0 diff
(100 %id)
BE206923 lung, small cell carcinoma .b 30 to 683 1 to 656       656/656
(100 %)
7 diff
(99.0 %id)
BF983870 duodenal adenocarcinoma, cell line, small intestine .b 30 to 797 1 to 762       762/938
(81 %)
21 diff
(97.8 %id)
BM458319 lymph, lymphoma, cell line .b 30 to 834 1 to 810       810/1135
(71 %)
15 diff
(98.7 %id)
BM927335 lymph, lymphoma, cell line .b 30 to 795 1 to 776       776/1159
(66 %)
14 diff
(98.8 %id)
BQ053450 blood, natural killer cells, cell line .b 30 to 832 1 to 817       817/1120
(72 %)
21 diff
(98.2 %id)
BQ958125 carcinoma, cell line, Prostate .b 30 to 837 1 to 819       819/916
(89 %)
11 diff
(98.8 %id)
BU849059 ovary, teratocarcinoma, cell line .b 30 to 888 1 to 863       863/865
(99 %)
10 diff
(98.9 %id)
CX868667 embryonic stem .b 30 to 717 1 to 688   fully sequenced,   688/688
(100 %)
0 diff
(100 %id)
CX784826 human embryonic stem cells .b 30 to 765 1 to 736       736/736
(100 %)
0 diff
(100 %id)
CX786282 human embryonic stem cells .b 30 to 755 1 to 726       726/726
(100 %)
1 diff
(99.9 %id)
CV808219 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 30 to 859 1 to 838       838/894
(93 %)
20 diff
(97.8 %id)
CV813380 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 30 to 747 1 to 718       718/726
(98 %)
2 diff
(99.8 %id)
CV802600 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 30 to 750 1 to 716       716/827
(86 %)
9 diff
(99.0 %id)
CD245568 White Matter .b 30 to 752 1 to 729       729/853
(85 %)
7 diff
(99.2 %id)
BU169720 embryonal carcinoma, cell line, testis .b 31 to 843 1 to 823       823/885
(92 %)
20 diff
(97.8 %id)
BQ233292 epithelioid carcinoma, Pancreas .b 31 to 898 1 to 872       872/875
(99 %)
28 diff
(96.8 %id)
CV808884 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 31 to 832 1 to 808       808/901
(89 %)
16 diff
(98.3 %id)
BC073754 Ovary, teratocarcinoma .b 32 to 1418 1 to 1387 exact available from MGC, AAA   1387/1387
(100 %)
0 diff
(100 %id)
CR599519 neuroblastoma .b 32 to 1395 1 to 1364 exact     1364/1364
(100 %)
0 diff
(100 %id)
CR602573 Placenta Cot 25-normalized .b 32 to 1410 1 to 1379 exact     1379/1379
(100 %)
0 diff
(100 %id)
BX446126 neuroblastoma .b 32 to 1076 1 to 1039       1039/1039
(100 %)
10 diff
(99.1 %id)
BX364877 Placenta Cot 25-normalized .b 32 to 1071 1 to 1028       1028/1033
(99 %)
15 diff
(98.6 %id)
BX387646 Placenta Cot 25-normalized .b 32 to 1113 1 to 1069       1069/1077
(99 %)
21 diff
(98.1 %id)
BU845659 ovary, teratocarcinoma, cell line .b 32 to 882 1 to 862       862/945
(91 %)
16 diff
(98.4 %id)
BQ942955 epidermoid carcinoma, cell line, lung .b 33 to 934 1 to 910       910/927
(98 %)
16 diff
(98.3 %id)
BU552825 ovary, teratocarcinoma, cell line .b 33 to 900 1 to 873       873/873
(100 %)
14 diff
(98.4 %id)
BU846205 ovary, teratocarcinoma, cell line .b 33 to 887 1 to 869       869/965
(90 %)
22 diff
(97.8 %id)
CX751939 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 33 to 799 1 to 765     Submitted on the opposite strand 765/767
(99 %)
3 diff
(99.7 %id)
BC044895 Bladder, transitional cell papilloma .b 37 to 1418 1 to 1382 exact available from MGC, AAA   1382/1382
(100 %)
0 diff
(100 %id)
EB388042 eye, optic nerve .b 37 to 852 1 to 816       816/816
(100 %)
0 diff
(100 %id)
BE257722 eye, retinoblastoma .b 38 to 704 1 to 664       664/684
(97 %)
6 diff
(99.2 %id)
CX760659 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 38 to 808 1 to 766     Submitted on the opposite strand 766/774
(98 %)
24 diff
(96.9 %id)
CX761223 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 38 to 822 1 to 774     Submitted on the opposite strand 774/831
(93 %)
18 diff
(97.9 %id)
CV812680 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 40 to 857 1 to 826   AAA   826/887
(93 %)
19 diff
(97.9 %id)
TI_154187797   .b 40 to 796 121 to 868       748/914
(81 %)
12 diff
(98.7 %id)
CN340707 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 47 to 681 1 to 635       635/635
(100 %)
0 diff
(100 %id)
CN340719 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 47 to 773 1 to 728       728/728
(100 %)
2 diff
(99.8 %id)
BG387902 embryonal carcinoma, cell line, testis .b 47 to 793 1 to 736       736/1064
(69 %)
14 diff
(98.7 %id)
BE784055 eye, retinoblastoma .b 50 to 797 1 to 739       739/818
(90 %)
11 diff
(98.7 %id)
DN602378 human embryonic stem cells .b 50 to 799 1 to 750       750/750
(100 %)
0 diff
(100 %id)
BQ688295 ductal carcinoma, cell line, Pancreas .b 52 to 784 1 to 738       738/919
(80 %)
17 diff
(98.2 %id)
BQ953231 eye, normal pigmented retinal epithelium .b 52 to 823 1 to 774       774/972
(79 %)
4 diff
(99.6 %id)
BC073990 Lung, large cell carcinoma .b 58 to 1417 1 to 1361 Q22P available from MGC, AAA   1361/1361
(100 %)
2 diff
(99.9 %id)
BQ069766 brain, neuroblastoma, cell line .b 60 to 752 1 to 697       697/1105
(63 %)
11 diff
(99.1 %id)
TI_154188548   .b 64 to 810 121 to 857       737/927
(79 %)
22 diff
(97.7 %id)
BQ228968 embryonal carcinoma, cell line, testis .b 76 to 934 1 to 867       867/869
(99 %)
12 diff
(98.7 %id)
BU857697 adenocarcinoma, cell line, breast .b 83 to 824 1 to 745       745/971
(76 %)
10 diff
(99.0 %id)
BU944185 adenocarcinoma, cell line, breast .b 83 to 919 1 to 843       843/954
(88 %)
15 diff
(98.5 %id)
CR610045 Placenta Cot 25-normalized .b 84 to 1395 1 to 1312 exact     1312/1312
(100 %)
0 diff
(100 %id)
BX328621 Placenta Cot 25-normalized .b 84 to 997 1 to 912       912/912
(100 %)
2 diff
(99.8 %id)
CX785642 human embryonic stem cells .b 93 to 913 1 to 821       821/821
(100 %)
0 diff
(100 %id)
BG574190 breast, mammary adenocarcinoma, cell line .b 145 to 959 1 to 816       816/816
(100 %)
3 diff
(99.7 %id)
BG577062 breast, mammary adenocarcinoma, cell line .b 185 to 949 1 to 765       765/765
(100 %)
0 diff
(100 %id)
M86842   .b 193 to 1418 16 to 1241 Q22P     1226/1241
(98 %)
6 diff
(99.6 %id)
CX867278 embryonic stem .b 200 to 802 1 to 603   fully sequenced,   603/603
(100 %)
0 diff
(100 %id)
BM710796 eye, fetal eyes .b 236 to 786 1 to 551       551/551
(100 %)
0 diff
(100 %id)
CR450353   .b 285 to 1337 1 to 1053       1053/1053
(100 %)
2 diff
(99.9 %id)
CV023540 mixed .b 285 to 944 1 to 660       660/660
(100 %)
2 diff
(99.7 %id)
CR605899 placenta .b 287 to 1421 1 to 1135       1135/1135
(100 %)
0 diff
(100 %id)
BG756248 B-cells, primary B-cells from tonsils (cell line) .b 291 to 1218 1 to 927       927/936
(99 %)
27 diff
(97.2 %id)
CR989909 T-Lymphocytes .b 297 to 987 1 to 691       691/699
(98 %)
1 diff
(99.9 %id)
BM693815 eye, lens .b 297 to 911 1 to 614       614/614
(100 %)
4 diff
(99.4 %id)
BG574457 breast, mammary adenocarcinoma, cell line .b 312 to 1179 1 to 870       870/870
(100 %)
17 diff
(98.1 %id)
BX418528 brain, fetal brain .b 334 to 1405 1057 to 1       1057/1131
(93 %)
20 diff
(98.3 %id)
BI917120 brain .b 362 to 1087 1 to 726       726/726
(100 %)
0 diff
(100 %id)
CR982016 T-Lymphocytes .b 363 to 1143 1 to 785       785/786
(99 %)
8 diff
(99.0 %id)
BQ233080 large cell carcinoma, lung .b 365 to 1371 1 to 1017       1017/1046
(97 %)
37 diff
(96.5 %id)
CR978977 T-Lymphocytes .b 378 to 1211 1 to 835       835/837
(99 %)
3 diff
(99.7 %id)
CR610254 Placenta Cot 25-normalized .b 382 to 1388 1 to 1007       1007/1007
(100 %)
0 diff
(100 %id)
CR610256 Placenta Cot 25-normalized .b 382 to 1421 1 to 1040       1040/1040
(100 %)
0 diff
(100 %id)
BX355851 Placenta Cot 25-normalized .b 382 to 915 1 to 530   fully sequenced,   530/530
(100 %)
1 diff
(99.9 %id)
BX343632 Placenta Cot 25-normalized .b 382 to 1421 1 to 1027       1027/1027
(100 %)
21 diff
(98.0 %id)
BG698014 skin .b 396 to 1178 1 to 785       785/789
(99 %)
5 diff
(99.4 %id)
BX415488 thymus .b 668 to 1382 715 to 1   fully sequenced,   715/715
(100 %)
0 diff
(100 %id)
BX356333 Placenta Cot 25-normalized .b 698 to 1389 690 to 1   fully sequenced,   690/690
(100 %)
3 diff
(99.6 %id)
CX868585 embryonic stem .b 712 to 1423 737 to 26   fully sequenced, AAA   712/712
(100 %)
3 diff
(99.6 %id)
BX398608 Placenta Cot 25-normalized .b 717 to 1386 670 to 1   fully sequenced,   670/670
(100 %)
0 diff
(100 %id)
BX375533 Neuroblastoma Cot 25-normalized .b 719 to 1363 644 to 1   fully sequenced,   644/644
(100 %)
3 diff
(99.6 %id)
CX867199 embryonic stem .b 772 to 1418 673 to 27   fully sequenced, AAA   647/647
(100 %)
6 diff
(99.1 %id)
BX355850 Placenta Cot 25-normalized .b 885 to 1359 505 to 31   fully sequenced,   475/475
(100 %)
0 diff
(100 %id)
BM667623 eye, fetal eyes .b 911 to 1418 526 to 19   AAA   508/508
(100 %)
0 diff
(100 %id)
BU738254 eye, lens .b 1008 to 1418 429 to 19   AAA   411/411
(100 %)
0 diff
(100 %id)
AU154248   .b 1162 to 1418 257 to 1       257/257
(100 %)
0 diff
(100 %id)
D90209   .c 1 to 2016 3 to 2015 Q22P tiling clone,   2015/2015
(100 %)
7 diff
(99.7 %id)
BM850502 stomach .c 1 to 547 3 to 550       550/550
(100 %)
1 diff
(99.9 %id)
DA039979 bladder .c 1 to 571 2 to 573   tiling clone, capped   572/572
(100 %)
2 diff
(99.7 %id)
AA633337 colon, colon tumor RER+ .c 1 to 474 472 to 1       472/473
(99 %)
17 diff
(96.5 %id)
AA889680   .c 1 to 474 471 to 1   tiling clone,   471/471
(100 %)
4 diff
(99.2 %id)
NM_001675.2   .c 1 to 2022 1 to 2022 exact RefSeq,   2022/2022
(100 %)
0 diff
(100 %id)
BM847645 myeloma .c 1 to 224 1 to 223       223/223
(100 %)
2 diff
(99.2 %id)
AA045153 uterus .c 18 to 331 1 to 309   fully sequenced,   309/309
(100 %)
55 diff
(82.3 %id)
AW206061   .c 18 to 546 529 to 1       529/533
(99 %)
0 diff
(100 %id)
DN997082 breast cancer, Mammary gland (cancer tissue) .c 18 to 578 9 to 569       561/569
(98 %)
6 diff
(99.0 %id)
TI_153990054   .c 18 to 547 586 to 57       530/746
(71 %)
0 diff
(100 %id)
AI523845 B-cell, chronic lymphotic leukemia .c 22 to 474 453 to 1       453/453
(100 %)
0 diff
(100 %id)
TI_157605126   .c 22 to 547 585 to 60       526/588
(89 %)
0 diff
(100 %id)
CN340694 embryonic stem cells, cell lines H1, H7, andH9 .c 23 to 662 1 to 641       641/641
(100 %)
4 diff
(99.4 %id)
AI003876   .c 23 to 435 440 to 34       407/440
(92 %)
0 diff
(100 %id)
BQ671739 epidermoid carcinoma, cell line, salivary gland .c 24 to 498 1 to 479       479/1112
(43 %)
14 diff
(98.8 %id)
AI139697 heart .c 25 to 547 523 to 1       523/523
(100 %)
1 diff
(99.9 %id)
W19671 parathyroid gland, parathyroid tumor .c 26 to 227 1 to 199       199/199
(100 %)
11 diff
(94.5 %id)
TI_157598423   .c 29 to 547 563 to 44       520/1018
(51 %)
0 diff
(100 %id)
CN340768 embryonic stem cells, cell lines H1, H7, andH9 .c 33 to 490 1 to 457       457/457
(100 %)
1 diff
(99.8 %id)
AI300242 placenta .c 36 to 529 490 to 1       490/494
(99 %)
17 diff
(96.6 %id)
AI356520 B-cell, chronic lymphotic leukemia .c 36 to 512 478 to 1       478/478
(100 %)
26 diff
(94.6 %id)
AI262016 adenocarcinoma, colon .c 37 to 529 493 to 1       493/493
(100 %)
0 diff
(100 %id)
CN340714 embryonic stem cells, DMSO-treated H9 cellline .c 43 to 290 1 to 249       249/249
(100 %)
1 diff
(99.6 %id)
AA465432 germinal center B cell .c 47 to 294 1 to 245   fully sequenced,   245/245
(100 %)
21 diff
(91.5 %id)
AI768314 pooled .c 51 to 499 449 to 1       449/449
(100 %)
4 diff
(99.2 %id)
AW043936 pooled .c 51 to 474 424 to 1       424/424
(100 %)
2 diff
(99.6 %id)
AI400789 B-cell, chronic lymphotic leukemia .c 52 to 529 476 to 1       476/483
(98 %)
1 diff
(99.8 %id)
TI_157599143   .c 53 to 547 551 to 52       500/1428
(35 %)
0 diff
(100 %id)
AW771549 Kidney .c 59 to 529 471 to 1       471/471
(100 %)
5 diff
(99.0 %id)
AI684371 B-cell, chronic lymphotic leukemia .c 61 to 520 460 to 1       460/462
(99 %)
0 diff
(100 %id)
BE676289 B-cell, chronic lymphotic leukemia .c 66 to 530 465 to 1       465/472
(98 %)
0 diff
(100 %id)
BE677790 pooled .c 69 to 547 479 to 1       479/479
(100 %)
2 diff
(99.6 %id)
AI052424 B-cell, chronic lymphotic leukemia .c 71 to 529 459 to 1       459/459
(100 %)
0 diff
(100 %id)
TI_157603962   .c 96 to 547 532 to 80       453/1144
(39 %)
0 diff
(100 %id)
AW511524 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 112 to 547 437 to 2       436/437
(99 %)
0 diff
(100 %id)
TI_153988389   .c 128 to 547 479 to 60       420/481
(87 %)
0 diff
(100 %id)
AW081761 pooled .c 135 to 474 343 to 1       343/343
(100 %)
4 diff
(98.9 %id)
AI189292 placenta .c 148 to 474 327 to 1       327/327
(100 %)
2 diff
(99.4 %id)
AI865191 lymph node, lymphoma, follicular mixed small and largecell .c 166 to 497 332 to 1       332/333
(99 %)
5 diff
(98.5 %id)
AW204645   .c 171 to 546 376 to 1       376/376
(100 %)
2 diff
(99.5 %id)
BF000379 colon, colon tumor, RER+ .c 203 to 547 345 to 1       345/345
(100 %)
0 diff
(100 %id)
N89947 parathyroid gland, parathyroid tumor .c 261 to 432 172 to 1       172/172
(100 %)
3 diff
(98.3 %id)
AA465361 germinal center B cell .c 283 to 474 189 to 1   fully sequenced,   189/189
(100 %)
3 diff
(98.5 %id)
BF000680 colon, colon tumor, RER+ .c 292 to 547 256 to 1       256/256
(100 %)
1 diff
(99.7 %id)
AA045106 uterus .c 317 to 474 164 to 1   fully sequenced,   164/164
(100 %)
9 diff
(94.6 %id)
CN273595 embryonic stem cells, DMSO-treated H9 cellline .c 398 to 539 1 to 142       142/142
(100 %)
0 diff
(100 %id)
AA307122 colon .c 507 to 922 1 to 416       416/416
(100 %)
1 diff
(99.8 %id)
AW242019 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 539 to 918 1 to 382     Submitted on the opposite strand 382/389
(98 %)
8 diff
(98.0 %id)
AI142653 pooled .c 540 to 1103 1 to 561     Submitted on the opposite strand 561/566
(99 %)
29 diff
(94.9 %id)
BI906816 leukocyte .c 544 to 1288 1 to 746       746/746
(100 %)
3 diff
(99.6 %id)
TI_57233287   .c 544 to 1288 34 to 779       746/779
(95 %)
8 diff
(99.0 %id)
AI382599 B-cell, chronic lymphotic leukemia .c 558 to 898 1 to 337     Submitted on the opposite strand 337/337
(100 %)
4 diff
(98.9 %id)
AI365442 B-cell, chronic lymphotic leukemia .c 558 to 924 1 to 362     Submitted on the opposite strand 362/407
(88 %)
6 diff
(98.6 %id)
AA044821 uterus .c 562 to 1129 1 to 562     Submitted on the opposite strand 562/568
(98 %)
9 diff
(98.5 %id)
BF342614 brain, glioblastoma with EGFR amplification .c 586 to 1285 13 to 704       692/755
(91 %)
17 diff
(97.8 %id)
BE163151 head_neck .c 587 to 825 1 to 238       238/238
(100 %)
4 diff
(98.4 %id)
AA135556 uterus .c 587 to 878 1 to 301     Submitted on the opposite strand 301/393
(76 %)
10 diff
(97.5 %id)
AA533632 colon .c 587 to 1013 1 to 427     Submitted on the opposite strand 427/437
(97 %)
6 diff
(98.7 %id)
AA932928 pooled .c 588 to 1101 1 to 513     Submitted on the opposite strand 513/513
(100 %)
31 diff
(94.0 %id)
BE163317 head_neck .c 596 to 860 4 to 266       263/266
(98 %)
8 diff
(97.0 %id)
BE927120 colon_normal .c 601 to 860 1 to 259       259/259
(100 %)
9 diff
(96.6 %id)
AW603175 colon_normal .c 608 to 836 232 to 4       229/232
(98 %)
0 diff
(100 %id)
BF082989 colon_normal .c 608 to 865 280 to 22       259/280
(92 %)
0 diff
(100 %id)
AV651871 corresponding non cancerous liver tissue .c 629 to 1107 31 to 509     Submitted on the opposite strand 479/509
(94 %)
6 diff
(98.9 %id)
R75614 breast .c 638 to 956 1 to 319     Submitted on the opposite strand 319/324
(98 %)
2 diff
(99.4 %id)
BE007447 breast_normal .c 654 to 833 180 to 1     Submitted on the opposite strand 180/189
(95 %)
3 diff
(98.5 %id)
BQ956218 sciatic nerve .c 657 to 1422 1 to 779       779/944
(82 %)
24 diff
(97.5 %id)
AW362830 colon .c 660 to 876 16 to 229       214/229
(93 %)
6 diff
(97.4 %id)
AA044865 uterus .c 701 to 1309 607 to 3     Submitted on the opposite strand 605/639
(94 %)
9 diff
(98.6 %id)
CR456384   .c 703 to 1969 1 to 1267 exact tiling clone,   1267/1267
(100 %)
0 diff
(100 %id)
BF171953 blood .c 707 to 1057 1 to 348       348/348
(100 %)
9 diff
(97.5 %id)
BI045614 prostate_normal .c 717 to 1099 1 to 383       383/383
(100 %)
10 diff
(97.4 %id)
BM174919 hippocampus .c 763 to 995 51 to 283       233/283
(82 %)
8 diff
(97.2 %id)
CB129425 cervix, Uterine .d 1 to 313 3 to 316       316/316
(100 %)
3 diff
(99.1 %id)
BP321017 placenta .d 1 to 580 3 to 582   tiling clone,   582/582
(100 %)
2 diff
(99.7 %id)
CB125802 Liver .d 1 to 312 2 to 313       313/313
(100 %)
0 diff
(100 %id)
BM847338 lymph node, stomach .d 1 to 312 2 to 313       313/313
(100 %)
1 diff
(99.7 %id)
CA407014 adipose .d 30 to 312 1 to 283       283/283
(100 %)
0 diff
(100 %id)
CF128619 Chondrosarcoma Lung Metastasis cell lines, lung .d 307 to 1072 1 to 765       765/765
(100 %)
4 diff
(99.5 %id)
TI_154194735   .d 307 to 1326 51 to 1063   tiling clone,   1013/1074
(94 %)
41 diff
(96.2 %id)
BI088474 cervix .d 308 to 1072 1 to 767       767/767
(100 %)
4 diff
(99.5 %id)
BU177108 melanotic melanoma, skin .d 368 to 1236 1 to 871   tiling clone,   871/871
(100 %)
14 diff
(98.4 %id)
BM552932 amelanotic melanoma, cell line, skin .d 390 to 1327 1 to 938   tiling clone,   938/950
(98 %)
9 diff
(99.1 %id)
CN340736 embryonic stem cells, cell lines H1, H7, andH9 .d 411 to 1061 1 to 651       651/651
(100 %)
0 diff
(100 %id)
W32946 parathyroid gland, parathyroid tumor .e 1 to 478 1 to 479   tiling clone,   479/479
(100 %)
17 diff
(96.5 %id)
BE799525 lung, small cell carcinoma .e 20 to 813 30 to 822   tiling clone,   793/830
(95 %)
31 diff
(96.3 %id)
BQ949398 sciatic nerve .e 72 to 845 1 to 777 Q22P S166F G168R V169G L170P ... tiling clone,   777/931
(83 %)
14 diff
(98.5 %id)
BE563836 adenocarcinoma, Pancreas .f 1 to 791 34 to 842 G66R L67V V68G S69Q P70S ... tiling clone,   809/847
(95 %)
38 diff
(95.6 %id)
BP216547 corpus callosum .f 5 to 586 1 to 582   tiling clone,   582/582
(100 %)
4 diff
(99.4 %id)
AK296028 subthalamic nucleus .g 1 to 1519 2 to 1521 exact tiling clone,   1521/1521
(100 %)
2 diff
(99.9 %id)
DC338710 subthalamic nucleus .g 1 to 557 2 to 562       562/562
(100 %)
4 diff
(99.3 %id)
DC338865 subthalamic nucleus .g 1 to 562 2 to 565       565/565
(100 %)
3 diff
(99.5 %id)
AU107691   .g 1 to 49 2 to 50       50/50
(100 %)
0 diff
(100 %id)
DC427708 cord Blood .g 4 to 534 1 to 531   tiling clone,   531/531
(100 %)
2 diff
(99.7 %id)
BP353270   .g 4 to 586 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
CX784700 human embryonic stem cells .g 30 to 792 1 to 764       764/764
(100 %)
2 diff
(99.8 %id)
BE256125 eye, retinoblastoma .g 48 to 599 1 to 554       554/555
(99 %)
6 diff
(99.0 %id)
BI056814 placenta_normal .g 244 to 739 505 to 11       495/537
(92 %)
0 diff
(100 %id)
BF849225 lung_normal .g 277 to 673 14 to 410       397/411
(96 %)
3 diff
(99.3 %id)
DN601689 human embryonic stem cells .g 311 to 903 1 to 593   tiling clone,   593/593
(100 %)
0 diff
(100 %id)
TI_59392452   .g 408 to 1215 83 to 894       812/812
(100 %)
13 diff
(98.4 %id)
BM014434 breast, mammary adenocarcinoma, cell line .g 409 to 1215 1 to 811       811/811
(100 %)
13 diff
(98.4 %id)
AA362566   .g 444 to 745 1 to 302       302/302
(100 %)
0 diff
(100 %id)
AW959371   .g 444 to 966 1 to 526       526/528
(99 %)
16 diff
(97.0 %id)
CN340721 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 533 to 1253 1 to 721       721/721
(100 %)
0 diff
(100 %id)
CR984279 T-Lymphocytes .g 596 to 1456 1 to 861 E256X     861/861
(100 %)
0 diff
(100 %id)
BG333572 melanotic melanoma, skin .h 1 to 753 1 to 739 exact tiling clone,   739/782
(94 %)
17 diff
(97.9 %id)
BF928524 nervous_tumor .h 134 to 558 1 to 427   tiling clone,   427/439
(97 %)
17 diff
(96.2 %id)
EC513691.
matches multiple genes
Prostate C.a-u 868 to 951 12 to 93     also hits gene ATF4C 82/93
(88 %)
6 diff
(93.6 %id)
410 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI